Clinical Trials Browser

Phase 1/2 × Advanced Solid Tumor × Irinotecan × Clear all

NCT06139211 2024-12-20

A Phase Ib/II Study Of JS015 Combination Therapy in Advanced Solid Tumors

Phase 1/2 Recruiting

Other solid neoplasm

Advanced Solid Tumor